MetaCap

Obsidian Therapeutics Inc. (OBX)

NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.00-0.15 (-1.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

OBX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$741.29M
EPS (TTM)
-$6.52
52-week range
9.60 – 49.97
Day range
11.76 – 12.30
Volume / Avg
336.50K / 511.50K
Beta
—

52-week range

$9.60$49.97

OBX stock today

Shares of Obsidian Therapeutics (OBX) finished lower on Nov 20 at $12.00, a drop of 1.23% or $0.15 per share, versus the S&P 500's 3.70% decline. Shares are 76.0% below their 52-week high of $49.97, set on Aug 4, 2026 and 25.0% above the 52-week low of $9.60, near the bottom of the past year's range. Obsidian Therapeutics has posted a net loss over the last twelve months (EPS of -$6.52), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Obsidian Therapeutics

Company profile

Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Madan Jagasia M.D., M.S.
Headquarters
Cambridge, MA
Employees
87

Analyst forecast

Forecast

Consensus (5 analysts)

strong_buy

Avg. price target

$38.67+222.25%

  • Strong buy 1
  • Buy 4
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $32.00High $42.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-1.23 vs $-0.43
Surprise
-186.05%

OBX news

All OBX news

Obsidian Therapeutics peers

Health Care sector
OBX peer companies
CompanyPrice% ChgMarket capCompare
IVAInventiva S.A. American Depository Shares3.14-8.99%$750.78Mvs OBX
ARDXArdelyx Inc.2.99-2.29%$751.60Mvs OBX
RIGLRigel Pharmaceuticals Inc.40.09-2.67%$754.89Mvs OBX
ORICOric Pharmaceuticals Inc.7.36-4.42%$764.94Mvs OBX
COLLCollegium Pharmaceutical Inc.24.72-1.94%$768.18Mvs OBX
IRWDIronwood Pharmaceuticals Inc. Class A4.70-0.21%$778.09Mvs OBX
SNDXSyndax Pharmaceuticals Inc.8.72-4.49%$785.05Mvs OBX
VSTMVerastem Inc.6.33-7.73%$797.67Mvs OBX

Indexes, lists and sector

Obsidian Therapeutics stock FAQ

What is Obsidian Therapeutics's stock price today?

OBX last traded at $12.00 as of Nov 20, 4:00 PM EST, down 1.23% on the day. Prices are delayed at least 15 minutes.

Who is Obsidian Therapeutics's CEO?

Dr. Madan Jagasia M.D., M.S. is the chief executive officer of Obsidian Therapeutics Inc., which has about 87 employees.

What is the OBX 52-week high?

The 52-week high for OBX is $49.97 and the 52-week low is $9.60. The stock is currently 76.0% below its high.

Compare OBX